Feature | ABPA# | SAFS (proposed) |
Clinical features | ||
Asthma | Any severity | Severe¶ |
Pulmonary infiltrates (history) | Yes, which resolve with corticosteroids | No |
Eosinophilia | Yes, if not on systemic corticosteroids | Not studied, but not required |
Central bronchiectasis | Yes, but many patients with early disease do not have this feature | No |
Thick mucous plugs | Yes, usually | Unknown |
Chronic rhinosinusitis, with or without nasal polyps | Occasional | Sometimes |
Fungal features | ||
Aspergillus precipitins positive (2× asthma control) | Yes (almost all cases) | No |
Aspergillus IgG test positive (2× asthma control) | Yes | No |
Aspergillus prick test positive (>3 mm) | Yes | Yes or no+ |
Other fungal skin tests positive (>3 mm) | No§ | Yes or no+ |
Serum IgE elevated (>1000 IU·mL−1) | Yes (may be only >500 IU·mL−1, especially if on corticosteroids) | No (<1000 IU·mL−1) |
Aspergillus-specific RAST test positive (2× asthma control) | Yes | Yes or no+ |
Other fungal RAST test positive | No§ | Yes or no+ |
Airways colonised by Aspergillus fumigatus | Yes | Unknown |
Ig: immunoglobulin; RAST: radioallergosorbent test. #: as defined by Ricketti et al. 126 and Patterson et al. 127; ¶: typically British Thoracic Society level 4 or equivalent; +: at least one fungal skin or RAST test positive (better and more specific tests may emerge in the future); §: there are rare instances of bronchopulmonary mycosis due to other fungi, with typical clinical features.